Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ana Lúcia Sousa
Detection of Anti-Infliximab Antibodies Is Impacted by Antibody Titer, Infliximab Level and IgG4 Antibodies: A Systematic Comparison of Three Different Assays
Therapeutic Advances in Gastroenterology
Gastroenterology
Related publications
PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications: Abstract PWE-109 Table
Gut
Gastroenterology
Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Infliximab (Anti–Tumor Necrosis Factor Α Antibody)
Archives of Dermatology
Detection of Anti-Hla Antibodies by Flow Cytometer
SAT0152 Real-Life Infliximab and Adalimumab Trough Level and Anti-Drug Antibody Measurements in Rheumatology: The Finnish Experience
A Dermatomyositis and Scleroderma Overlap Syndrome With a Remarkable High Titer of Anti-Exosome Antibodies
Reumatismo
Rheumatology
Correlation Between Elevation of Serum Antinuclear Antibody Titer and Decreased Therapeutic Efficacy in the Treatment of Behçet’s Disease With Infliximab
Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Suppression of Anti-Drug Antibodies to Infliximab or Adalimumab With the Addition of an Immunomodulator in Patients With Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
IgG4 Antibodies and Cancer-Associated Inflammation
OncoImmunology
Oncology
Allergy
Immunology
